Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

41.85
Delayed Data
As of 3:59pm ET
 -2.25 / -5.10%
Today’s Change
17.25
Today|||52-Week Range
44.95
+65.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues51.6M56.8M62.4M57.6M
 
 
 
 
 
Cost of Goods Sold2.1M2.8M3.1M2.2M
 
 
 
 
 
Depreciation And Amortization688.0K600.0K671.0K741.0K
 
 
 
 
 
 
Operating ExpensesGross Income48.9M53.4M58.6M54.6M
 
 
 
 
 
General Expenses37.2M33.5M42.3M37.8M
 
 
 
 
 
Research And Development11.1M7.9M13.3M9.6M
 
 
 
 
 
Total Operating Expenses40.0M37.0M46.1M40.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income11.6M19.8M16.3M16.8M
 
 
 
 
 
Extraordinary Credit123.0K125.0K100.0K54.0K
 
 
 
 
 
Extraordinary Charge0.000.00-289.0K-101.0K
 
 
 
Interest Expense On Debt1.5M1.2M951.0K1.0M
 
 
 
 
 
Other Expenses2.0K-1.0K-13.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.7M19.1M15.6M16.2M
 
 
 
 
 
Income Taxes-405.0K-42.7M-1.2M-5.9M
 
 
 
 
 
Net Income10.3M61.8M14.3M10.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.4M49.5M49.7M50.2M
 
 
 
 
 
Shares To Calculate EPS Diluted51.7M52.0M52.0M52.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.18$1.18$0.26$0.19
 
 
 
 
 
EPS Diluted$0.18$1.18$0.28$0.19